Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Glenmark India, US, Latin America operations all contribute to the financial results of Glenmark Pharmaceuticals Ltd. the parent company located in Mumbai, India.
I don't believe this any more than when it was stated Glenmark USA was a separate entity from Glenmark India. This was proven to be pure BS. Nor did I believe the allegation Elite traded on the German Frankfurt exchange. Also proven to BS. There are many more examples that could be cited.
This might be a good job for those interns to look into. Say, did they uncover any more info on whether Glenmark India was related to Glenmark USA? LMAO
BS alert. . .
Not true. . .completely false:
All I can say is. . .ludricrous nonsense
I have. . .the dates are fine
Nope all is good with the dates.
Nah. . .nothing wrong with the dates
Hm. . ."Breaking News" crapola as opposed to actual facts from a verifiable source. I'll take the latter. LMAO
Whicket. . .thank you for the excellent DD and it really blows this nonsensical, ludicrous statement out of the water:
Here is what I don't BELIEVE:
Elite has stated via PR's and audited 10K's which ANDA's have been submitted and approved by the FDA. The IQVIA (formerly QuintilesIMS Health Data)states the annual sales of branded/generic sales for each of Elite's ANDA's. This info easily accessible via their website. Anyway, bottom line. . .it's my money. . .my
investment. . .my choice as to which sources of DD I choose to help me decide whether to invest or not. Other prospective investors will have to make the same choices when conducting DD. If they don't like what they see then they don't have to invest. It's simple. . .really.
Good morning NASDAQ. The audited 10K's also includes all of the information summarized in Meshcan's table. It would take some digging to verify all of the info listed there but you are correct. The table info is verifiable via the PR's, CC's and 10K's. Meshcan was kind enough to summarize all of this info onto one page.
N2K. . .I read that too and immediately wrote it off as the result of a lack of proper education.
Well, I have translated this and the conclusion is. . . pure BS.
Thanks N2K. Yes there is a lot of nonsense being posted about Elite and too little time to correct it all.
Yes I know all about the FOS syndrome. . .like the time Elite traded on the Frankfurt Germany exchange. No proof was ever provided to back that up.
Yes it is BS because Nasrat never said this: "nasrat said it probably would mount to nothing for elite". Re-read what he actually stated. LMAO
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=144316628
Nah, that is BS.
What ludicrous nonsense. Would it not be better to be proactive in eliminating the source of addiction (non-ADT opiates) with the use of abuse deterrent formulations?
Well. . .if you were to listen to the CC audio and note Nasrat's tone, I would think the conclusion would be he was adding some levity to the question of whether the employees were happy. He goes on to say everybody is happy given the two recent FDA approvals.
Here is the full quote on the memo:
"Now we are getting low on questions. Now people are asking what are the moods of the employees. Are they happy with the recent events? And also -- feeling about FDA? Well the employees are happy because Carter issued them a memo asking them to be happy, definitely we are all happy with the most recent events getting two approvals in less than two months is always a very positive, especially after we went through last year with the challenges. I always feel positive about Elite regardless of the FDA so this doesn’t change much."
Nasdaq. . .like you, I can wait to see how this all plays out. I have all the time in the world. GLTU
N2k. . . excellent response. Thanks for weighing in on this.
In other words. . .maybe it will, maybe it won't. A conservative response from Nasrat. How else could he respond? He's waiting for the results of the PD study like a lot of other people are. A far cry from the previously posted BS stating, "even nasrat says it won’t do much for elite".
BS alert
I call BS on that.
So opinions are made that "employees are dropping like flies" and "many employees are quitting" and no proof is provided back this up. Okay. . .I guess it's pure BS then.
Where is this coming from? Please tell us exactly how many employees have quit?
What a load of BS!!!
Thomas. . .that laughable allegation was made two years ago, last year and now this year. It's pure BS. Nothing to worry about. GLTU
Oh, what the hell. . .I have nothing to lose. I am going to tout myself as a self appointed pharma expert. LMAO
Well...as as I am concerned, nobody is a pharma expert on this thread.
Google, Yahoo, Bing, etc. are only search engines used to find pertinent information. I give no credence to unsubstantiated opinions.
Thanks, but I will go with what I consider to be a more reliable source.
Yes we all know the FDA is a sleek, fast moving entity when it comes to processing applications. LOL
Nonsense. . .a pharma business can't just wake up one morning and decide to resume manufacturing of a discontinued product. There is due process required with the FDA before this can happen.
Yes, the R/S topic has been discussed several times during the CC's. These references to the split were in response to questions submitted prior to the events. Nasrat's response has been it was his preference to build the share price organically to qualify uplisting to NASDAQ but if necessary an R/S will be completed and only from a position of strength.
Okay. . .I just noticed first quote was posted by someone else. Second quote is predicting 2 cents or less.